Zenas BioPharma Ownership | Who Owns Zenas BioPharma?


OverviewForecastRevenueFinancialsChart

Zenas BioPharma Ownership Summary


Zenas BioPharma is owned by 7.91% institutional investors, 26.22% insiders, and 65.87% retail investors. Sr one capital management, lp is the largest institutional shareholder, holding 11.73% of ZBIO shares.

ZBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockZenas BioPharma7.91%26.22%65.87%
SectorHealthcare Stocks 42.53%10.81%46.67%
IndustryBiotech Stocks 45.24%10.75%44.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Sr one capital management, lp4.91M11.73%$109.04M
Fmr4.82M11.51%$107.01M
Enavate sciences gp3.76M8.98%$83.50M
Nea management company2.73M6.53%$60.69M
Novo2.00M4.78%$44.40M
Fairmount funds management1.89M4.52%$42.02M
Federated hermes1.86M4.45%$41.33M
Nvp associates1.84M4.39%$40.81M
Deerfield management company, l.p. (series c)1.56M3.73%$34.70M
Blackrock funding, inc. /de1.23M2.93%$27.28M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Enavate sciences gp3.76M25.50%$83.50M
Nvp associates1.84M24.58%$40.81M
Sr one capital management, lp4.91M15.77%$109.04M
Pivotal bioventure partners investment advisor779.04K10.00%$17.29M
Fairmount funds management1.89M3.78%$42.02M
Nea management company2.73M3.33%$60.69M
Novo2.00M2.86%$44.40M
Superstring capital management lp96.67K2.11%$2.15M
Vivo capital1.18M2.11%$26.27M
Sectoral asset management152.03K2.08%$3.37M

Top Buyers

HolderShares% AssetsChange
Fmr4.82M0.01%1.50M
Vanguard group1.16M0.00%170.55K
Invesco145.80K0.00%145.80K
Blackrock funding, inc. /de1.23M0.00%133.03K
Geode capital management470.04K0.00%96.42K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors---744.03K
Arrowmark colorado824.67K0.34%-269.67K
Novo2.00M2.86%-250.00K
Catalio capital management, lp---215.31K
Eversept partners, lp158.74K0.24%-166.74K

New Positions

HolderShares% AssetsChangeValue
Invesco145.80K0.00%145.80K$3.24M
Stempoint capital lp38.74K0.17%38.74K$860.07K
Creative planning11.88K0.00%11.88K$263.78K
American century companies10.98K0.00%10.98K$243.78K
Russell investments group1.34K-1.34K$29.86K

Sold Out

HolderChange
Mrp capital investments-35.00
Corebridge financial-7.53K
Stoneridge investment partners-10.96K
Sei investments-12.14K
Alpine global management-12.91K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202524-66.67%3,311,937-90.27%70.12%10-78.72%4-63.64%
Jun 30, 20257212.50%34,055,19122.15%811.83%4767.86%11-45.00%
Mar 31, 2025664.76%32,487,0833.18%7713.66%27-42.55%20233.33%
Dec 31, 20246448.84%31,696,95628.35%240.69%4811.63%6-
Sep 30, 202443-24,696,152-59-43---

Recent Insider Transactions


DateNameRoleActivityValue
Oct 09, 2025Nunn Jason Raleigh-Buy$1.20M
Oct 09, 2025SR ONE CAPITAL MANAGEMENT, LLC-Buy$1.20M
Oct 09, 2025SR ONE CAPITAL MANAGEMENT, LLC-Buy$1.20M
Oct 09, 2025ENRIGHT PATRICK G-Buy$249.99K
Oct 09, 2025ENRIGHT PATRICK G-Buy$2.00M

Insider Transactions Trends


DateBuySell
2025 Q43-
2025 Q2--
2025 Q12-
2024 Q44-

ZBIO Ownership FAQ


Who Owns Zenas BioPharma?

Zenas BioPharma shareholders are primarily institutional investors at 7.91%, followed by 26.22% insiders and 65.87% retail investors. The average institutional ownership in Zenas BioPharma's industry, Biotech Stocks , is 45.24%, which Zenas BioPharma falls below.

Who owns the most shares of Zenas BioPharma?

Zenas BioPharma’s largest shareholders are Sr one capital management, lp (4.91M shares, 11.73%), Fmr (4.82M shares, 11.51%), and Enavate sciences gp (3.76M shares, 8.98%). Together, they hold 32.23% of Zenas BioPharma’s total shares outstanding.

Does Blackrock own Zenas BioPharma?

BlackRock is not among the top 10 institutional shareholders of Zenas BioPharma.

Who is Zenas BioPharma’s biggest shareholder by percentage of total assets invested?

Enavate sciences gp is Zenas BioPharma’s biggest shareholder by percentage of total assets invested, with 25.50% of its assets in 3.76M Zenas BioPharma shares, valued at 83.5M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools